CALTRATE Safety Questions, CALTRATE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CALTRATE. Our extensive database of CALTRATE adverse events and CALTRATE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CALTRATE
CALTRATE Safety Reports
Total CALTRATE reports: 8.CALTRATE FDA safety alerts: No.
Reported hospitalizations: 7.
Take CALTRATE Side Effects Survey or Share Your CALTRATE Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported CALTRATE problem on Jan 25, 2007. Male patient, weighting 180.0 lb, was diagnosed with osteoporosis and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: calcinosis, implant site reaction, vision blurred. CALTRATE dosage: unknown. During the same period patient was treated with FOSAMAX. Patient recovered.
CALTRATE problem was reported by a Health Professional from UNITED STATES on May 24, 2006. Female patient, 61 years of age, weighting 133.6 lb, was diagnosed with mineral supplementation, breast cancer and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: alopecia, arthralgia, liver abscess, mastectomy, radiation pneumonitis, rash pruritic. CALTRATE dosage: unknown. During the same period patient was treated with FEMARA, HERCEPTIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported CALTRATE problem on May 24, 2006. Female patient, 61 years of age, weighting 133.6 lb, was diagnosed with mineral supplementation, breast cancer and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: alopecia, arthralgia, liver abscess, mastectomy, radiation pneumonitis, rash pruritic. CALTRATE dosage: unknown. During the same period patient was treated with FEMARA, HERCEPTIN. Patient was hospitalized. Patient recovered.
CALTRATE problem was reported by a Health Professional from UNITED STATES on May 24, 2006. Female patient, 61 years of age, weighting 133.6 lb, was diagnosed with mineral supplementation, breast cancer and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: alopecia, arthralgia, liver abscess, mastectomy, radiation pneumonitis, rash pruritic. CALTRATE dosage: unknown. During the same period patient was treated with FEMARA, HERCEPTIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported CALTRATE problem on May 24, 2006. Female patient, 61 years of age, weighting 133.6 lb, was diagnosed with mineral supplementation, breast cancer and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: alopecia, arthralgia, liver abscess, mastectomy, radiation pneumonitis, rash pruritic. CALTRATE dosage: unknown. During the same period patient was treated with FEMARA, HERCEPTIN. Patient was hospitalized. Patient recovered.
CALTRATE problem was reported by a Physician from FRANCE on Mar 08, 2006. Female patient, 74 years of age, weighting 141.1 lb, was diagnosed with osteoporosis, insomnia, gastrooesophageal reflux disease, hypertension and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, asthenia, blood pressure increased, gastroenteritis, headache, hip arthroplasty, memory impairment, nausea, nosocomial infection. CALTRATE dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, FORTEO, INIPOMP, AMLOR, HYPERIUM. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CALTRATE problem on Mar 08, 2006. Female patient, 74 years of age, weighting 141.1 lb, was diagnosed with osteoporosis, insomnia, gastrooesophageal reflux disease, hypertension and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, asthenia, blood pressure increased, gastroenteritis, headache, hip arthroplasty, memory impairment, nausea, oedema peripheral. CALTRATE dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, FORTEO, INIPOMP, AMLOR, HYPERIUM. Patient was hospitalized. Patient recovered.
CALTRATE problem was reported by a Health Professional from AUSTRALIA on Sept 21, 2007. Female patient, weighting 101.4 lb, was diagnosed with osteoporosis, hypothyroidism, ephelides, rash, pruritus and was treated with CALTRATE. After drug was administered, patient experienced the following problems/side effects: fatigue, hypoalbuminaemia, oedema peripheral. CALTRATE dosage: 1200 MG. During the same period patient was treated with VITAMIN CAP, PANAMAX, OROXINE, CHLORSIG, DIPROSONE, CELESTONE, ALPHA KERI OIL, ALPHA KERI LOTION. Patient was hospitalized. Patient recovered.